Oral regimen ‘delays onset of MS’
Oral regimen ‘delays onset of MS’
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 776 Views
-
Last post by NHE
-
- 0 Replies
- 2170 Views
-
Last post by frodo
-
- 0 Replies
- 1056 Views
-
Last post by NHE
-
- 0 Replies
- 1279 Views
-
Last post by frodo
-
- 1 Replies
- 983 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1519 Views
-
Last post by NHE
-
- 0 Replies
- 1995 Views
-
Last post by vesta
-
- 1 Replies
- 1084 Views
-
Last post by Petr75